+Search query
-Structure paper
Title | Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens. |
---|---|
Journal, issue, pages | Sci Transl Med, Vol. 15, Page eadf5668-eadf5668, Year 2023 |
Publish date | Aug 17, 2022 (structure data deposition date) |
Authors | Zhao, J. / Cochrane, C.S. / Najeeb, J. / Gooden, D. / Sciandra, C. / Fan, P. / Lemaitre, N. / Newns, K. / Nicholas, R.A. / Guan, Z. ...Zhao, J. / Cochrane, C.S. / Najeeb, J. / Gooden, D. / Sciandra, C. / Fan, P. / Lemaitre, N. / Newns, K. / Nicholas, R.A. / Guan, Z. / Thaden, J.T. / Fowler Jr., V.G. / Spasojevic, I. / Sebbane, F. / Toone, E.J. / Duncan, C. / Gammans, R. / Zhou, P. |
External links | Sci Transl Med / PubMed:37556556 |
Methods | X-ray diffraction |
Resolution | 2.034 Å |
Structure data | PDB-8e4a: |
Chemicals | ChemComp-ZN: ChemComp-UFX: ChemComp-HOH: |
Source |
|
Keywords | BIOSYNTHETIC PROTEIN / LpxC / lipid A |